This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Top ETF Stories of January Worthy of Attention in February
by Sanghamitra Saha
A few top ETF stories ruled the month of January and deserve a close look in February.
Cannabis ETF (CNBS) Hits New 52-Week High
by Sweta Killa
This cannabis ETF hits a new 52-week high. Are more gains in store for this ETF?
Small Caps Outperform to Start 2021: 5 Best ETFs of Last Week
by Sweta Killa
The Russell 2000 Index is up 5.9%, outperforming the gains of 4.8% for the S&P 400 Mid Cap Index and 1.8% for the S&P 500 Index.
ETFs to Buy as Tilray-Aphria Merger Creates Cannabis Giant
by Sweta Killa
Investors seeking to take advantage of the merger deal between Tilray and Aphria could invest in any of the cannabis ETFs.
5 Best Small-Cap ETFs as Russell 2000 Tops S&P 500 YTD
by Sanghamitra Saha
Small-cap stocks look poised to match the soaring large-cap U.S. indexes in 2021. Buy these top-ranked ETFs to play the trend.
5 Small-Cap Sector ETFs Beating the Russell 2000
by Sweta Killa
We have presented five ETFs that have easily crushed the Russell 2000 Index over the past three months.
Cannabis ETFs Set to Soar in 2021 on More U.S. Legalization
by Sweta Killa
Given the prospect of loosening regulations and increased legalization, cannabis stocks are set to soar in 2021.
Why Cannabis Stocks & ETFs Are Soaring
by Sanghamitra Saha
Cannabis stocks and the ETFs have surged lately on hopes of the legalization of marijuana at the federal level under Biden presidency.
5 ETF Areas of November That Are Up At Least 25%
by Sanghamitra Saha
Back-to-back upbeat vaccine update, stimulus hopes and a divided government have boosted Wall Street in November.
Top ETF of November & Its Best Stocks
by Sweta Killa
Amplify Seymour Cannabis ETF (CNBS) topped the list of the best-performing ETFs of November with impressive returns of more than 47%.